[1]
Y. W. Al-Omari, S. A. Mustafa, A. H. Saleh, and W. S. Abdel-Razaq, “Bleeding disorder, a newly recognized adverse event following sacubitril/valsartan therapy”, EJCRIM, vol. 13, no. 4, Mar. 2026, doi: 10.12890/2026_006178.